Chapter
Licensed
Unlicensed
Requires Authentication
12. Date rape drugs and hallucinogens
-
Colleen Dodich
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter i
- Contents vii
- Author Index xvii
- Foreword xxiii
- Abbreviations xxv
- 1. Introduction: Substance abuse in adolescents and young adults 1
-
Section I: Etiology and diagnosis
- 2. Neurobiology of substance use disorders 13
- 3. Genetic influences on substance abuse disorders 27
- 4. Essential diagnostic considerations 39
-
Section II: Treatment
- 5 Psychosocial treatments for substance use disorders 63
- 6. General pharmacotherapy principles 79
- 7. Use of pharmacological agents for smoking cessation 85
- 8. Marijuana: Current concepts and conundrums 109
- 9. Primary care management of alcohol use disorders of adolescents and young adults 145
- 10. Opioids and prescription drugs 163
- 11. Illicit stimulant abuse in adolescents and young adults 173
- 12. Date rape drugs and hallucinogens 195
- 13. The role of the pediatrician and primary care clinician 215
-
Section III: Special populations
- 14. Substance use disorders in adolescents and young adults: Comorbidity and treatment 239
- 15. Adolescent girls and substance abuse: Recent trends, risk factors, and consequences 257
- 16. Prescription stimulant and other substance abuse in college students 281
- 17. Sports doping by adolescent athletes 297
- 18. Prenatal drug exposure: Maternal and fetal issues 319
-
Section IV: New challenges and policy
- 19. New drugs of abuse in the 21st century 337
- 20. Estimating the societal burden of substance abuse: Advantages and limitations of current methodologies 345
- 21. The pros and cons of legalization 365
- 22. Internet resources and treatment facilities 381
-
Section V: Acknowledgments
- 23. About the editors 389
- 24. About the Department of Pediatric and Adolescent Medicine, Western Michigan University School of Medicine 391
- 25. About the National Institute of Child Health and Human Development in Israel 393
- 26. About the book series Health, Medicine and Human Development 397
- Index 399
Chapters in this book
- Frontmatter i
- Contents vii
- Author Index xvii
- Foreword xxiii
- Abbreviations xxv
- 1. Introduction: Substance abuse in adolescents and young adults 1
-
Section I: Etiology and diagnosis
- 2. Neurobiology of substance use disorders 13
- 3. Genetic influences on substance abuse disorders 27
- 4. Essential diagnostic considerations 39
-
Section II: Treatment
- 5 Psychosocial treatments for substance use disorders 63
- 6. General pharmacotherapy principles 79
- 7. Use of pharmacological agents for smoking cessation 85
- 8. Marijuana: Current concepts and conundrums 109
- 9. Primary care management of alcohol use disorders of adolescents and young adults 145
- 10. Opioids and prescription drugs 163
- 11. Illicit stimulant abuse in adolescents and young adults 173
- 12. Date rape drugs and hallucinogens 195
- 13. The role of the pediatrician and primary care clinician 215
-
Section III: Special populations
- 14. Substance use disorders in adolescents and young adults: Comorbidity and treatment 239
- 15. Adolescent girls and substance abuse: Recent trends, risk factors, and consequences 257
- 16. Prescription stimulant and other substance abuse in college students 281
- 17. Sports doping by adolescent athletes 297
- 18. Prenatal drug exposure: Maternal and fetal issues 319
-
Section IV: New challenges and policy
- 19. New drugs of abuse in the 21st century 337
- 20. Estimating the societal burden of substance abuse: Advantages and limitations of current methodologies 345
- 21. The pros and cons of legalization 365
- 22. Internet resources and treatment facilities 381
-
Section V: Acknowledgments
- 23. About the editors 389
- 24. About the Department of Pediatric and Adolescent Medicine, Western Michigan University School of Medicine 391
- 25. About the National Institute of Child Health and Human Development in Israel 393
- 26. About the book series Health, Medicine and Human Development 397
- Index 399